• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Intuitive Ventures brings in $150M to support minimally invasive care startups

Intuitive Ventures brings in $150M to support minimally invasive care startups

December 4, 2023 By Sean Whooley

Intuitive Ventures LogoIntuitive Ventures announced today that it closed a $150 million funding round to support early-stage minimally invasive care companies.

Surgical robotics pioneer Intuitive Surgical launched Intuitive Ventures with $100 million in funding more than three years ago. The early-stage fund earmarked its latest round of funding, labeled “Fund II,” for three areas of investment focus. It wants to support improved access and coordination, precision diagnostics and interventions and secure, enriched digital ecosystems.

Intuitive Ventures said in a news release that it aims to lower the barriers to care with efficient, cost-effective, accessible care. By leveraging the intersection of medtech, life sciences and therapeutics, it believes it can support diagnostics and interventions, too. The fund also hopes to utilize the potential of novel healthcare data to enhance minimally invasive care.

“We are proud of the strides achieved by the Ventures team over the past three years. They have been instrumental in accelerating innovation in minimally invasive care and diligent in advising their portfolio companies,” said Gary Guthart, CEO of Intuitive Surgical. “The Ventures team is a key member of our future forward group, who identify and foster innovations in minimally invasive care. Fund II deepens Intuitive’s commitment to the broad ecosystem of innovators working to improve patient outcomes.”

More about Intuitive Ventures and its leadership

Since the launch of Intuitive Ventures in 2020, the fund has provided support to more than 10 “transformative startups,” Intuitive said. It expects Fund II to continue the group’s successful strategy and invest in new, visionary startups. Those startups also have access to the Intuitive Surgical network and corporate oversight.

Intuitive said it selected Murielle Thinard McLane, who joined the team earlier this year, to lead the fund. She takes over as managing partner and head of Intuitive Ventures from Dr. Oliver Keown. Keown decided to pursue a new opportunity as a startup founder and CEO but intends to continue supporting the fund as a venture partner.

Thinard McLane brings more than 20 years of experience building and scaling organizations. Her past includes time spent as an investor, entrepreneur and Fortune 500 executive.

“It’s an honor to lead Intuitive Ventures in this next stage of growth, and continue to develop our portfolio of transformative companies and high-quality investment partners,” she said. “We take great pride in serving as value-add investors, providing unique strategic perspectives, and aligning our success with the success of our portfolio companies and fellow investors. With Fund II, Intuitive Ventures will further scale its impactful approach, and help accelerate the creation of innovative minimally invasive care solutions.”

Filed Under: Business/Financial News, Digital Health, Featured, Funding Roundup, Health Technology, News Well, Robotic-Assisted, Surgical, Surgical Robotics Tagged With: Intuitive Surgical, Intuitive Ventures

More recent news

  • Abbott partners with Berry Street to add nutrition coaching to Lingo
  • GE HealthCare taps retiring AT&T CFO for board of directors
  • Corcym delivers first-in-human implant of Memo 4D Curve mitral repair ring
  • Boston Scientific MedSurg, Asia Pacific leader to retire
  • DePuy Synthes launches next-generation automated fracture fixation system

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy